Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -129.91x is 77% below its 3-year average of -73.55x, around the middle of its 3-year range (-334.60x–16.73x).
393.89% below its 12-month average of -26.30x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -55.82x.
INTEREST COVERAGE RATIO
-129.91x
INTEREST COVERAGE RATIO AVG TTM
-26.30x
INTEREST COVERAGE RATIO AVG 3Y
-73.55x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-393.89%
CURRENT VS 3Y AVG
-76.63%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1937.80%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.11M
Interest Coverage Ratio
-129.91x
TTM Avg
-26.30x
3Y Avg
-73.55x
5Y Avg
N/A
Market Cap
$9.86M
Interest Coverage Ratio
-54.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.38M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.51M
Interest Coverage Ratio
-219.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.75M
Interest Coverage Ratio
-12.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.11M | -129.91x | -26.30x | -73.55x | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.08M | -57.26x | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -54.10x | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.38M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.62M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | -219.72x | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.75M | -12.65x | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.59M | -19.65x | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.57M | -1.99x | N/A | N/A | N/A |
Interest Coverage
-129.9x
Debt/Equity
N/A
Current Ratio
1.57
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -55.82x |
| 2026-03-31 | 16.73x |
| 2025-12-31 | -39.82x |
| 2024-12-31 | -2.95x |
| 2024-09-30 | -334.60x |
| 2024-06-30 | -45.80x |
| 2024-03-31 | -197.88x |
| 2023-09-30 | -0.74x |
| 2023-06-30 | -1.06x |
